phone icon  Int'l : +1 (503) 505-6949
0
Shopping Cart is Empty..
$ 0

Global Bioinformatics Market (Sectors, Product & Services, Applications, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

 Pages:151
pubn Published: May 2014
tab_nTables: 48
aut_nAuthor(s): Debbie Shields
 p_n

The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc. 

The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives. The factor limiting this market is the need for skilled personnel due to the complexity of the bioinformatics tools used. The other limiting factors are the saturation of the pharmaceutical sectors and lack of common data formats. The factors that would provide opportunity for the growth of this market are standardization of databases, need for integration systems and solutions and need to control data overload due to the piling-up of data due to the numerous experiments conducted. The reason to study this market is to understand the current trends and applications in the bioinformatics field along with in depth analysis of the segments.

Bioinformatics Technology and Services Market Analysis

The bioinformatics technology and services market is segmented into knowledge management tools, bioinformatics platforms and bioinformatics services. The Bioinformatics platform market was the highest revenue generating market in 2013. This was due to the increased application usage of the platforms in various genomic applications. However, the Knowledge Management Tools is expected to emerge as the highest revenue generating segment by 2020 due to the increasing number of data generated due to the increasing clinical trials.

Bioinformatics Application Market Analysis

The bioinformatics application market is segmented based on, metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics and others. The Genomics was the highest revenue generating market among the bioinformatics application market in 2013. This was due to the increased applications in drug discovery and development using bioinformatics tools. The tools proved to be cost and time efficient for the pharmaceutical companies. The Chemoinformatics and Drug Design is expected to be the highest revenue generating segment by 2020 due to its ability to use information in the selection and designing of the drug cycle. 

Bioinformatics Sector Market Analysis

The bioinformatics sector is segmented into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics and others. The Medical bioinformatics was and is forecast to be the highest revenue generating market through 2020. This was due to the increasing application of drug discovery and development using bioinformatics tools, which were also used in the preventive medicine and gene therapy. 

Bioinformatics Geographic Market Analysis

The geography segment is segmented into North America, Europe, Asia Pacific and RoW. North America was the highest revenue generating region in 2013 due to the wider adoption of advanced technology in the region. North America was followed by Europe  as the second largest revenue generating segment in 2013 due to the continuous adoption of new technology in the field of drug discovery and development. The market scenario for bioinformatics is expected to remain same throughout the forecast period.

Competitive Landscape

The key companies profiled in this report are Accelrys, Inc., Affymetrix, Inc., Agilent Technologies, Inc., Geneva bioinformatics, Non linear dynamics, Quest Diagnostics, Inc., Life Technologies corp., Illumina, Bruker Daltonics, Inc., and Biomax Informatics AG. The key strategies opted by the market players are Product Launch, Agreement and Collaboration. 

High Level Analysis

The market analysis is done based on Porter’s five forces model and Value chain analysis. According to the Porter’s five forces model the bargaining power of the supplier’s is low due to the presence of many bioinformatics service providers and the threat from internal substitutes of this market is moderate. According to the value chain analysis the major revenue is generated from the drug discovery segment. In the past, the R&D activity in the biotechnology and pharmaceutical industry had a restrictive budget. However, due to the advancement in the IT solutions, the cost involved in the R&D activity has become cost and time efficient. 

Key Benefits

  • The report provides detailed analysis about the driving and limiting factors of the Bioinformatics market, which would give a deeper understanding of the subject and help in analyzing the various applications of bioinformatics 
  • The application market helps in analyzing the various application segments, thus helping the stakeholders understand opportunities in the various fields of bioinformatics market 
  • To understand the bioinformatics market and its segments and to gain a deeper understanding of trends adopted
  • The report analyzes the market conditions in a comprehensive and quantitative manner and forecast market trends and techniques used in bioinformatics
  • The market is forecast in terms of revenue throughout 2013 to 2020.

Key Deliverables

The global Bioinformatics market is segmented based on technology & services, application, sector and geography.

BY TECHNOLOGY AND SERVICES

  • Knowledge Management Tools
    • Generalized knowledge management tools
    • Specialized knowledge management tools
  • Bioinformatics Platforms 
    • Sequence analysis platforms
    • Sequence alignment platforms
    • Sequence manipulation platforms
    • Structural analysis platforms
    • Others
  • Bioinformatics Services
    • Sequencing services
    • Database and management
    • Data Analysis
    • Others

BY APPLICATION

  • Metabolomics
  • Molecular Phylogenetics
  • Transcriptomics
  • Proteomics
  • Chemoinformatics
  • Genomics
  • Others

BY SECTOR

  • Medical Bioinformatics
  • Animal Bioinformatics
  • Agriculture Bioinformatics
  • Academics 
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific
  • RoW

CHAPTER 1. INTRODUCTION

1.1 Report Description
1.2 Key Market Segments
1.3Key benefits
1.4Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. BIOINFORMATICS MARKET OVERVIEW

3.1 Market definition and scope
3.2 Introduction

3.2.1 Components
3.2.2 Biological Databases
3.2.3 Applications of bioinformatics

3.3 Trends and challenges faced by the industry
3.4 Bioinformatics cloud services
3.5 Next-generation sequencing services
3.6 Value chain analysis - bioinformatics and drug development
3.7 Bioinformatics in the drug development process
3.8 Patent analysis
3.9 Key findings

3.9.1 Top ten factors impacting Bioinformatics market
3.9.2 Top winning strategies in the Bioinformatics market
3.9.3 Top investment pockets in Bioinformatics market

3.9.3.1 Top investment markets by application
3.9.3.2 Top investment markets by sector

3.10 Porters five-forces analysis

3.10.1 Bargaining power of suppliers is low
3.10.2 Bargaining power of the buyer is high
3.10.3 Threats for new entrants
3.10.4 High competition
3.10.5 Threat from substitutes

3.11 Case study: Supercomputing Cluster
3.12 Regulations
3.13 Market dynamics

3.13.1 Drivers

3.13.1.1 Need for integrated data
3.13.1.2 Increasing growth in proteomics and genomics
3.13.1.3 Drug discovery and development
3.13.1.4 Government initiatives

3.13.2 Restraints

3.13.2.1 Need for skilled PERSONNEL
3.13.2.2 Common data formats
3.13.2.3 Pharmaceutical sector saturation

3.13.3 Opportunities

3.13.3.1 Standardization
3.13.3.2 Need for integrated solutions and systems
3.13.3.3 Data overload

CHAPTER 4. GLOBAL BIOINFORMATICS MARKET BY TECHNOLOGY AND SERVICES

4.1 Global bioinformatics market by technology, platforms and services
4.2 Bioinformatics Content/Knowledge Management Tools

4.2.1 Global bioinformatics knowledge management tools market by type
4.2.2 Bioinformatics knowledge management tools market by geography
4.2.3 Generalized knowledge management tools

4.2.3.1 Bioinformatics Generalized Knowledge Management Tools market by geography

4.2.4 Specialized knowledge management

4.2.4.1 Bioinformatics Specialized Knowledge Management Tools market by geography

4.3 Bioinformatics Platforms

4.3.1 Global bioinformatics platforms market by type
4.3.2 Bioinformatics platforms market by geography
4.3.3 Sequence Analysis Platforms

4.3.3.1 Bioinformatics Sequence Analysis platform market by geography

4.3.4 Sequence alignment platforms

4.3.4.1 Bioinformatics Sequence alignment platform market by geography

4.3.5 Sequence Manipulation Platforms

4.3.5.1 Bioinformatics Sequence Manipulation platform market by geography

4.3.6 Structural Analysis Platforms

4.3.6.1 Bioinformatics Structural Analysis platform market by geography

4.3.7 Other Platforms

4.3.7.1 Bioinformatics others platform market by geography

4.4 Bioinformatics services

4.4.1 Global bioinformatics service market
4.4.2 Bioinformatics services market by geography
4.4.3 Sequencing Services

4.4.3.1 Bioinformatics Sequencing Services market by geography

4.4.4 Database and Management

4.4.4.1 Bioinformatics database &management Services market by geography

4.4.5 Data Analysis

4.4.5.1 Bioinformatics data analysis Services market by geography

4.4.6 Others (Data services) market

4.4.6.1 Bioinformatics other Services market by geography

CHAPTER 5. GLOBAL BIOINFORMATICS MARKET BY APPLICATION

5.1 Global bioinformatics application market
5.2 Genomics

5.2.1 Bioinformatics genomics application market by geography

5.3 Chemoinformatics and Drug Design

5.3.1 Bioinformatics chemoinformatics and drug design application market by geography

5.4 Proteomics

5.4.1 Bioinformatics Proteomics application market by geography

5.5 Transcriptomics

5.5.1 Bioinformatics Transcriptomics application market by geography

5.6 Metabolomics

5.6.1 Bioinformatics Metabolomics application market by geography

5.7 Molecular Phylogenetics

5.7.1 Bioinformatics Molecular Phylogenetics application market by geography

5.8 Other application market

5.8.1 Pharmacogenomics
5.8.2 Pharmacoproteomics
5.8.3 Bioinformatics other application market by geography

CHAPTER 6. GLOBAL BIOINFORMATICS MARKET BY SECTOR

6.1 Global Bioinformatics market by sector
6.2 Medical bioinformatics

6.2.1 Drug development
6.2.2 Molecular medicine
6.2.3 Preventive medicine
6.2.4 Gene therapy
6.2.5 Medical Bioinformatics sector market by geography

6.3 Animal Bioinformatics

6.3.1 Animal Bioinformatics sector market by geography

6.4 Agricultural bioinformatics

6.4.1 Crop yield improvement
6.4.2 Pest resistance
6.4.3 Plant resistance against abiotic stresses
6.4.4 Improve nutritional quality
6.4.5 Agriculture bioinformatics sector market by geography

6.5 Academics

6.5.1 Global Bioinformatics Academics sector market by geography

6.6 Others (Microbial genome)

6.6.1 Bioinformatics other sectors market by geography

CHAPTER 7. GLOBAL BIOINFORMATICS MARKET BY GEOGRAPHY

7.1 North America

7.1.1 North America bioinformatics market

7.2 Europe

7.2.1 Europe bioinformatics market

7.3 Asia pacific

7.3.1 Asia Pacific bioinformatics market

7.4 RoW

7.4.1 RoW bioinformatics market

CHAPTER 8. COMPANY PROFILES

8.1 Accelrys, Inc.

8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Business performance
8.1.4 Strategic moves and developments
8.1.5 SWOT Analysis of Accelrys, Inc

8.2 Affymetrix, Inc.

8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Business performance
8.2.4 Strategic moves and developments
8.2.5 SWOT Analysis of Affymetrix, Inc

8.3 Agilent Technologies, Inc.

8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Business performance
8.3.4 Strategic moves and developments
8.3.5 SWOT Analysis of Agilent technologies, Inc

8.4 Geneva Bioinformatics (Genebio) SA

8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Strategic moves and developments
8.4.4 SWOT Analysis of Geneva Bioinformatics (GeneBio) SA

8.5 Nonlinear Dynamics

8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Strategic moves and developments
8.5.4 SWOT Analysis of Nonlinear Dynamics Ltd.

8.6 Quest Diagnostics, Inc.

8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Business performance
8.6.4 Strategic moves and developments

8.6.4.1 Primary Strategies
8.6.4.2 Secondary Strategies

8.6.5 SWOT Analysis of Quest Diagnostics

8.7 Illumina

8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Business performance
8.7.4 Strategic moves and developments

8.7.4.1 Primary Strategies
8.7.4.2 Secondary Strategies

8.7.5 SWOT Analysis of Illumina, Inc.

8.8 Bruker Daltonics Inc

8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Business performance
8.8.4 Strategic moves and developments

8.8.4.1 Primary Strategies

8.8.5 SWOT Analysis of Bruker Daltonics, Inc.

8.9 Biomax Informatics AG

8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Strategic moves and developments

8.9.3.1 Primary Strategies
8.9.3.2 Secondary Strategies

8.9.4 SWOT Analysis of Biomax Informatics AG

8.10 Life Technologies Corporation

8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Business performance
8.10.4 Strategic moves and developments

8.10.4.1 Primary Strategies
8.10.4.2 Secondary Strategies

8.10.5 SWOT Analysis of Life technologies

LIST OF TABLES

TABLE 1 BIOINFORMATICS MARKET BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 2 LIST OF PATENT
TABLE 3 GLOBAL BIOINFORMATICS MARKET BY TECHNOLOGY, PLATFORMS AND SERVICES, 2013-2020($MILLION)
TABLE 4 GLOBAL BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET BY TYPE, 2013-2020 ($MILLION)
TABLE 5 BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 6 BIOINFORMATICS GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 7 BIOINFORMATICS SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY GEOGRAPHY 2013 2020 ($MILLION)
TABLE 8 GLOBAL BIOINFORMATICS MARKET, BY PLATFORMS
TABLE 9 BIOINFORMATICS PLATFORMS MARKET BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 10 BIOINFORMATICS SEQUENCE ANALYSIS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 11 BIOINFORMATICS SEQUENCE ALIGNMENT PLATFORM MARKET, BY GEOGRAPHY 2013 2020 ($MILLION)
TABLE 12 BIOINFORMATICS SEQUENCE MANIPULATION PLATFORM MARKET, BY GEOGRAPHY 2013 2020 ($MILLION)
TABLE 13 BIOINFORMATICS STRUCTURAL ANALYSIS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 14 BIOINFORMATICS OTHERS PLATFORM MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 15 GLOBAL BIOINFORMATICS MARKET, BY SERVICES 2013-2020 ($MILLION)
TABLE 16 BIOINFORMATICS SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 17 BIOINFORMATICS SEQUENCING SERVICES MARKET, BY GEOGRAPHY 2013 2020 ($MILLION)
TABLE 18 BIOINFORMATICS DATABASE &MANAGEMENT SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 19 BIOINFORMATICS DATA ANALYSIS SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 20 BIOINFORMATICS OTHER SERVICES MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 21 GLOBAL BIOINFORMATICS MARKET, BY APPLICATION 2013-2020($MILLION)
TABLE 22 BIOINFORMATICS GENOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 23 BIOINFORMATICS CHEMOINFORMATICS AND DRUG DESIGN APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 24 BIOINFORMATICS PROTEOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 25 BIOINFORMATICS TRANSCRIPTOMICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 26 BIOINFORMATICS METABOLOMICS APPLICATION MARKET, BY GEOGRAPHY 2013 2020 ($MILLION)
TABLE 27 BIOINFORMATICS MOLECULAR PHYLOGENETICS APPLICATION MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 28 BIOINFORMATICS OTHER APPLICATION MARKET, BY GEOGRAPHY 2013 2020 ($MILLION)
TABLE 29 GLOBAL BIOINFORMATICS MARKET BY SECTOR, 2013-2020($MILLION)
TABLE 30 MEDICAL BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 31 ANIMAL BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 32 AGRICULTURE BIOINFORMATICS SECTOR MARKET, BY GEOGRAPHY 2013 2020 ($MILLION)
TABLE 33 GLOBAL BIOINFORMATICS ACADEMICS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 34 BIOINFORMATICS OTHERS SECTORS MARKET, BY GEOGRAPHY 2013-2020 ($MILLION)
TABLE 35 NORTH AMERICAN BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 36 EUROPE BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 37 ASIA PACIFIC BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 38 ROW BIOINFORMATICS MARKET, 2013-2020 ($MILLION)
TABLE 39 ACCELRYS, INC BUSINESS SNAPSHOT
TABLE 40 AFFYMETRIX, INC. BUSINESS SNAPSHOT
TABLE 41 AGILENT TECHNOLOGIES, INC BUSINESS SNAPSHOT
TABLE 42 GENEVA BIOINFORMATICS (GENEBIO) SA BUSINESS SNAPSHOT
TABLE 43 NONLINEAR DYNAMICS LTD. BUSINESS SNAPSHOT
TABLE 44 QUEST DIAGNOSTICS BUSINESS SNAPSHOT
TABLE 45 ILLUMINA, INC. BUSINESS SNAPSHOT
TABLE 46 BRUKER DALTONICS, INC. BUSINESS SNAPSHOT
TABLE 47 BIOMAX INFORMATICS AG BUSINESS SNAPSHOT
TABLE 48 LIFE TECHNOLOGIES BUSINESS SNAPSHOT

LIST OF FIGURES

FIG. 1 VALUE CHAIN ANALYSIS
FIG. 2 COMPARATIVE ANALYSIS OF APPLICATION MARKET
FIG. 3 PATENT REGISTERED IN THE U.S., EUROPE AND JAPAN
FIG. 4 TOP FACTORS IMPACTING IVD MARKET (2013-2020)
FIG. 5 TOP WINNING STRATEGIES
FIG. 6 TOP INVESTMENT MARKET BY APPLICATIONS
FIG. 7 TOP INVESTMENT MARKETS BY SECTOR
FIG. 8 PORTERS FIVE FORCE ANALYSIS
FIG. 9 TYPES OF GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
FIG. 10 TYPES OF SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
FIG. 11 TYPES OF SEQUENCE ANALYSIS PLATFORMS
FIG. 12 TYPES OF STRUCTURAL ANALYSIS PLATFORMS
FIG. 13 STEPS IN DATABASE & MANAGEMENT
FIG. 14 GENOMIC APPLICATIONS BASED ON CLINICAL FIELDS (2012)
FIG. 15 GEOGRAPHIC LOCATION OF NEXT GENERATION SEQUENCING (NGS) SUPPLIERS USED IN GENOMICS
FIG. 16 CHEMOINFORMATICS WORKFLOW
FIG. 17 ROLE OF CHEMOINFORMATICS IN DRUG DISCOVERY
FIG. 18 ROLE OF TRANSCRIPTOMICS IN DRUG DISCOVERY
FIG. 19 ROLE OF METABOLOMICS IN DIAGNOSTICS
FIG. 20 ANALYSIS OF METABOLOMICS DATA
FIG. 21 PHYLOGENETIC FOUR STEP ANALYSIS
FIG. 22 FARM ANIMAL GENOMICS
FIG. 23 CHALLENGES FACED BY BIOINFORMATICS IN ASIA PACIFIC REGION
FIG. 24 TOTAL REVENUE BY GEOGRAPHY
FIG. 25 SWOT ANALYSIS OF ACCELRYS, INC.
FIG. 26 TOTAL REVENUE BY GEOGRAPHY
FIG. 27 TOTAL REVENUE BY BUSINESS UNIT
FIG. 28 SWOT ANALYSIS OF AFFYMETRIX, INC.
FIG. 29 AGILENT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
FIG. 30 AGILENT TECHNOLOGIES - REVENUE MIX BY GEOGRAPHY (2013)
FIG. 31 KEYSIGHT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
FIG. 32 KEYSIGHT TECHNOLOGIES - REVENUE MIX BY END MARKET (2013)
FIG. 33 SWOT ANALYSIS OF AGILENT TECHNOLOGIES, INC
FIG. 34 SWOT ANALYSIS OF GENEVA BIOINFORMATICS (GENEBIO) SA
FIG. 35 SWOT ANALYSIS OF NONLINEAR DYNAMICS LTD.
FIG. 36 PERCENTAGE OF REVENUE GENERATION BY BUSINESS UNITS
FIG. 37 SWOT ANALYSIS OF QUEST DIAGNOSTICS
FIG. 38 SWOT ANALYSIS OF ILLUMINA, INC.
FIG. 39 SWOT ANALYSIS OF BRUKER DALTONICS, INC.
FIG. 40 SWOT ANALYSIS OF BIOMAX INFORMATICS AG
FIG. 41 FINANCIAL REVENUES BY END MARKETS (2012)
FIG. 42 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 43 SWOT ANALYSIS OF LIFE TECHNOLOGIE

Bioinformatics is a combination of molecular biology with computer science and is essential to storing genetic information for understanding (identifying can be used) human diseases and for further identification of molecular targets for discovering drugs. The bioinformatics is utilized in various fields such as statistics, computer science, engineering and mathematics involved in studying and processing of biological data. Bioinformatics helps in the development of software tools and methods for organizing, analyzing, retrieving and storing biological data and genetic information, all of which have varied applications in the field of  drug discovery and drug development, based on genetic information.

The tremendous application of bioinformatics forms a major part of almost all biological fields such as animal breeding, agriculture, preventive medicines, molecular medicine and various other uses. The Bioinformatics market is increasing due to growing demand in drug discovery & development and the increasing need for integrated data. Moreover, many researchers are focusing on prospective fields like proteomics and genomics R&D in these fields significantly augment the growth of the global bioinformatics market. Additionally, government authorities are taking initiatives for the standardization and management of overloaded data due to the frequent experiments conducted in various fields of medical science. However,  complex methods used in bioinformatics-related tools and the impending need for exceptionally skilled individuals is limiting the growth for the same. Nevertheless, decreased cost of genetic sequencing, owing  to the discovery of novel technologies and software tools along with the advancements  in the genomic field are responsible for augmenting the growth of this market. Other fruitful applications of bioinformatics include outsourcing of services for effective support to R&D activities at lower cost. 

icon_01
SINGLE
USER
icon_02
GROUP LICENSE
Icon_03
SITE
LICENSE
Icon_04
GLOBAL LICENSE
$4515
$5325
$7350
$10680
SUPPORT
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request
Get This Report
buy now
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1 (503) 505-6949

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED PRODUCTS
get_n
SIMILAR MARKET REPORTS
  • ...
    Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Initial symptoms of this disease include sore throat, headaches, fever and muscles pain. It causes hemorrhagic fever that leads to internal or external bleeding. EVD is widely prevalent in Central and Western Africa, and near tropical rainforests.
    Sep 2014 | Price: $2625(SU) €0(SU) £0(SU) | View Details >>
  • ...
    One of the key reasons for adoption of flow cytometry technology is its precise deliverance of results comparing to conventional methods such as ELISA. The emergence of this technology as one of the leading applications has brought various advancements in the diagnosis of diseases such as HIV and cancer as well as in research fields. With rising advancements in information technology, it finds application in drug discovery and development. Moreover, it is now used in hematopoietic stem cell research, multiparameter analysis and pharmacogenesis.
    Dec 2013 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body’s defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD)
    Jun 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications.
    Jul 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Nerve regeneration is a process used in the repair and replacement of damage nervous tissues, cells and cellular products. The nerve repair mechanism is generally used in the new glial cells, nervous, myelin, axons and synapse. The report is chiefly emphasizing on the commercial market of nerve repair and regeneration market. The rise in incidences of chronic diseases and increase in demand for the advance health care technologies is allowing health care industry to widen its presence in this market.
    Sep 2015 | View Details >>
  • ...
    Pain management, also termed as algiatry, is a branch of medicine that utilizes an interdisciplinary approach to ease and improve the quality of life of those suffering with pain. Pain is an ultimate result of trauma or tissue damage and the intensity of pain varies from person to person. Pain can be classified based on its occurrence and duration along with the affected body part. First line of treatment for pain management is pharmaceutical therapeutics or pain killer drugs, most of which are well known brands. The other pain management methods include physiotherapy, pain managing devices and chiropractor therapy.
    Sep 2015 | View Details >>
  • ...
    Optical imaging is a fiber optic and photonics based non-invasive technique that enables accurate viewing of organs, tissues and even molecules. The global optical imaging technology market comprises Photo-Acoustic Tomography (PAT), Optical Coherence Tomography (OCT), Near-Infrared Spectroscopy (NIRS), and Hyper-Spectral Imaging (HSI). This technology finds primary application in clinical research and pathology for disease diagnosis and treatment. Optical imaging market was valued $915.75 million in 2012 and is expected to grow at a CAGR of 12.2% during 2013-2020.
    Sep 2015 | View Details >>
  • ...
    Diagnostic Imaging is a technique used to examine the internal environment of the body. It helps in diagnosis and monitoring the progression of diseases. The evolution of diagnostic imaging techniques, has played a vital role in the development of healthcare industry. The diagnostic imaging market is flourished by innovations, such as ultra-fast and digital devices. It is yet imperative to find better economic alternatives which would help in the early diagnosis of disease.
    Sep 2015 | View Details >>